Definitive Cefazolin Therapy for Stabilized Adults with Community-Onset Escherichia coli, Klebsiella Species, and Proteus mirabilis Bacteremia: MIC Matters

Background: Cefazolin is in vitro active against wild isolates of Escherichia coli, Klebsiella species, and Proteus mirabilis (EKP), but clinical evidence supporting the contemporary susceptibility breakpoint issued by the Clinical and Laboratory Standards Institute (CLSI) are limited. Methods: Betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Chih-Chia, Chen, Po-Lin, Lee, Chung-Hsun, Yang, Chao-Yung, Lee, Ching-Chi, Ko, Wen-Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019784/
https://www.ncbi.nlm.nih.gov/pubmed/31936020
http://dx.doi.org/10.3390/jcm9010157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019784/
https://www.ncbi.nlm.nih.gov/pubmed/31936020
http://dx.doi.org/10.3390/jcm9010157

Ejemplares similares